Transcriptional network analysis for the regulation of left ventricular hypertrophy and microvascular remodeling

Journal of Cardiovascular Translational Research

Volumn 6, Issue 6, 2013, Pages 931-944

  Moreno Moral, Aida ^a   Mancini, Massimiliano ^b   D'Amati, Giulia ^b   Camici, Paolo ^c   Petretto, Enrico ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Cardiac fibrosis; Coronary microvascular remodeling; Gene regulatory networks; Left ventricular hypertrophy; Spontaneously Hypertensive Rat (SHR)

Indexed keywords

ARTICLE; CARDIOMYOPATHY; GENE CLUSTER; GENE IDENTIFICATION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; MOLECULAR MECHANICS; NIMAL EXPERIMENT; NIMAL MODEL; NIMAL TISSUE; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPONTANEOUSLY HYPERTENSIVE RAT; TRANSCRIPTION REGULATION;

ANIMALS; DISEASE MODELS, ANIMAL; FIBROSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MICROVESSELS; QUANTITATIVE TRAIT LOCI; RATS; RATS, INBRED SHR; SPECIES SPECIFICITY; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84890543391     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-013-9504-x     Document Type: Article

References (51)

1. Mancini, M.; Petretto, E.; Kleinert, C.; et al. (2013). Mapping genetic determinants of coronary microvascular remodeling in the spontaneously hypertensive rat. Basic Research in Cardiology, 108, 316. doi: 10.1007/s00395-012-0316-y.
2. Sharma, P.; Middelberg, R. P. S.; Andrew, T.; et al. (2006). Heritability of left ventricular mass in a large cohort of twins. Journal of Hypertension, 24, 321-324. doi: 10.1097/01.hjh.0000202815.18083.03.
3. Tousoulis, D.; Androulakis, E.; Papageorgiou, N.; et al. (2013). Genetic predisposition to left ventricular hypertrophy and the potential involvement of cystatin-C in untreated hypertension. American Journal of Hypertension, 26, 683-690. doi: 10.1093/ajh/hps089.
4. Rekhraj, S.; Gandy, S. J.; Szwejkowski, B. R.; et al. (2013). High-dose allopurinol reduces left ventricular mass in patients with ischemic heart disease. Journal of the American College of Cardiology, 61, 926-932. doi: 10.1016/j.jacc.2012.09.066.
5. Lynch, A. I.; Tang, W.; Shi, G.; et al. (2012). Epistatic effects of ACE I/D and AGT gene variants on left ventricular mass in hypertensive patients: the HyperGEN study. Journal of Human Hypertension, 26, 133-140. doi: 10.1038/jhh.2010.131.
6. Zhao, Y.; Wang, C.; Wu, J.; et al. (2013). Choline protects against cardiac hypertrophy induced by increased after-load. International Journal of Biological Sciences, 9, 295-302. doi: 10.7150/ijbs.5976.
7. Givvimani, S.; Kundu, S.; Narayanan, N.; et al. (2013). TIMP-2 mutant decreases MMP-2 activity and augments pressure overload induced LV dysfunction and heart failure. Archives of Physiology and Biochemistry, 119, 65-74. doi: 10.3109/13813455.2012.755548.
8. Hubner, N.; Wallace, C. A.; Zimdahl, H.; et al. (2005). Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nature Genetics, 37, 243-253. doi: 10.1038/ng1522.
9. Petretto, E.; Sarwar, R.; Grieve, I.; et al. (2008). Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nature Genetics, 40, 546-552.
10. McDermott-Roe, C.; Ye, J.; Ahmed, R.; et al. (2011). Endonuclease G is a novel determinant of cardiac hypertrophy and mitochondrial function. Nature, 478, 114-118. doi: 10.1038/nature10490.
11. Pravenec, M.; Klír, P.; Kren, V.; et al. (1989). An analysis of spontaneous hypertension in spontaneously hypertensive rats by means of new recombinant inbred strains. Journal of Hypertension, 7, 217-221.
12. Herrmann, J.; Kaski, J. C.; Lerman, A. (2012). Coronary microvascular dysfunction in the clinical setting: from mystery to reality. European Heart Journal, 33, 2771-2782b. doi: 10.1093/eurheartj/ehs246.
13. Camici, P. G.; Crea, F. (2007). Coronary microvascular dysfunction. The New England Journal of Medicine, 356, 830-840. doi: 10.1056/NEJMra061889.
14. Camici, P. G.; Olivotto, I.; Rimoldi, O. E. (2012). The coronary circulation and blood flow in left ventricular hypertrophy. Journal of Molecular and Cellular Cardiology, 52, 857-864. doi: 10.1016/j.yjmcc.2011.08.028.
15. Steiner, M. K.; Syrkina, O. L.; Kolliputi, N.; et al. (2009). Interleukin-6 overexpression induces pulmonary hypertension. Circulation Research, 104, 236-244. doi: 10.1161/CIRCRESAHA.108.182014 (28 p following 244).
16. Nickerson, M. M.; Song, J.; Meisner, J. K.; et al. (2009). Bone marrow-derived cell-specific chemokine (C-C motif) receptor-2 expression is required for arteriolar remodeling. Arteriosclerosis, Thrombosis, and Vascular Biology, 29, 1794-1801. doi: 10.1161/ATVBAHA.109.194019.
17. Smeda, J. S.; Lee, R. M.; Forrest, J. B. (1988). Structural and reactivity alterations of the renal vasculature of spontaneously hypertensive rats prior to and during established hypertension. Circulation Research, 63, 518-533.
18. Schadt, E. E. (2009). Molecular networks as sensors and drivers of common human diseases. Nature, 461, 218-223. doi: 10.1038/nature08454.
19. Hubner, N.; Wallace, C. A.; Zimdahl, H.; et al. (2005). Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nature Genetics, 37, 243-253.
20. Opgen-Rhein, R.; Strimmer, K. (2007). From correlation to causation networks: a simple approximate learning algorithm and its application to high-dimensional plant gene expression data. BMC Systems Biology, 1, 37. doi: 10.1186/1752-0509-1-37.
21. Pravenec, M.; Churchill, P. C.; Churchill, M. C.; et al. (2008). Identification of renal Cd36 as a determinant of blood pressure and risk for hypertension. Nature Genetics, 40, 952-954. doi: 10.1038/ng.164.
22. Langfelder, P.; Horvath, S. (2008). WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics, 9, 559. doi: 10.1186/1471-2105-9-559.
23. Kanehisa, M.; Goto, S.; Sato, Y.; et al. (2012). KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Research, 40, D109-D114. doi: 10.1093/nar/gkr988.
24. Huang, D. W.; Sherman, B. T.; Lempicki, R. A. (2009). Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Research, 37, 1-13. doi: 10.1093/nar/gkn923.
25. Rossin, E. J.; Lage, K.; Raychaudhuri, S.; et al. (2011). Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genetics, 7, e1001273. doi: 10.1371/journal.pgen.1001273.
26. Roider, H. G.; Manke, T.; O'Keeffe, S.; et al. (2009). PASTAA: identifying transcription factors associated with sets of co-regulated genes. Bioinformatics (Oxford, England), 25, 435-442. doi: 10.1093/bioinformatics/ btn627.
27. Sánchez, N. S.; Barnett, J. V. (2012). TGFβ and BMP-2 regulate epicardial cell invasion via TGFβR3 activation of the Par6/Smurf1/RhoA pathway. Cellular Signalling, 24, 539-548. doi: 10.1016/j.cellsig.2011.10.006.
28. Berk, B. C.; Fujiwara, K.; Lehoux, S. (2007). ECM remodeling in hypertensive heart disease. The Journal of Clinical Investigation, 117, 568-575. doi: 10.1172/JCI31044.
29. Yang, F.; Dong, A.; Mueller, P.; et al. (2012). Coronary artery remodeling in a model of left ventricular pressure overload is influenced by platelets and inflammatory cells. PloS One, 7, e40196. doi: 10.1371/journal. pone.0040196.
30. Basu, R.; Lee, J.; Morton, J. S.; et al. (2013). TIMP3 is the primary TIMP to regulate agonist-induced vascular remodelling and hypertension. Cardiovascular Research, 98, 360-371. doi: 10.1093/cvr/cvt067.
31. Chen, W.; Frangogiannis, N. G. (2013). Fibroblasts in post-infarction inflammation and cardiac repair. Biochimica et Biophysica Acta, 1833, 945-953. doi: 10.1016/j.bbamcr.2012.08.023.
32. Bo, S.; Mandrile, C.; Milanesio, N.; et al. (2012). Is left ventricular hypertrophy a low-level inflammatory state? A population-based cohort study. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD, 22, 668-676. doi: 10.1016/j.numecd.2010.11.004.
33. Dobaczewski, M.; Chen, W.; Frangogiannis, N. G. (2011). Transforming growth factor (TGF)-β signaling in cardiac remodeling. Journal of Molecular and Cellular Cardiology, 51, 600-606. doi: 10.1016/j.yjmcc.2010.10.033.
34. Xu, Y.; Wagner, D. R.; Bekerman, E.; et al. (2010). Connective tissue growth factor in regulation of RhoA mediated cytoskeletal tension associated osteogenesis of mouse adipose-derived stromal cells. PloS One, 5, e11279. doi: 10.1371/journal.pone.0011279.
35. Panek, A. N.; Posch, M. G.; Alenina, N.; et al. (2009). Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload. PloS One, 4, e6743. doi: 10.1371/journal.pone.0006743.
36. Gravning, J.; Ahmed, M. S.; Von Lueder, T. G.; et al. (2013). CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload. International Journal of Cardiology. doi: 10.1016/j.ijcard.2013.01.165.
37. Blom, I. E.; Van Dijk, A. J.; De Weger, R. A.; et al. (2001). Identification of human ccn2 (connective tissue growth factor) promoter polymorphisms. Molecular Pathology: MP, 54, 192-196.
38. Daniels, A.; Van Bilsen, M.; Goldschmeding, R.; et al. (2009). Connective tissue growth factor and cardiac fibrosis. Acta Physiologica (Oxford, England), 195, 321-338. doi: 10.1111/j.1748-1716.2008.01936.x.
39. Cecchi, F.; Olivotto, I.; Gistri, R.; et al. (2003). Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. The New England Journal of Medicine, 349, 1027-1035. doi: 10.1056/NEJMoa025050.
40. Zhang, R.; Crump, J.; Reisin, E. (2003). Regression of left ventricular hypertrophy is a key goal of hypertension management. Current Hypertension Reports, 5, 301-308.
41. Maron, M. S.; Olivotto, I.; Maron, B. J.; et al. (2009). The case for myocardial ischemia in hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 54, 866-875. doi: 10.1016/j.jacc.2009.04.072.
42. Lehner, B.; Lee, I. (2008). Network-guided genetic screening: building, testing and using gene networks to predict gene function. Briefings in Functional Genomics & Proteomics, 7, 217-227. doi: 10.1093/bfgp/eln020.
43. Benaglia, T.; Chauveau, D.; Hunter, D. R.; Young, D. (2009). mixtools: an R package for analyzing finite mixture models. Journal of Statistical Software, 32, 1-29.
44. Hebenstreit, D.; Fang, M.; Gu, M.; et al. (2011). RNA sequencing reveals two major classes of gene expression levels in metazoan cells. Molecular Systems Biology, 7, 497. doi: 10.1038/msb.2011.28.
45. Zhang, B.; Horvath, S. (2005). A general framework for weighted gene co-expression network analysis. Statistical Applications in Genetics and Molecular Biology, 4(1). doi: 10.2202/1544-6115.1128.
46. Kendall, M. (1938). A new measure of rank correlation. Biometrika, 30, 81-89.
47. Huang, D. W.; Sherman, B. T.; Lempicki, R. A. (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols, 4, 44-57. doi: 10.1038/nprot.2008.211.
48. Bryne, J. C.; Valen, E.; Tang, M.-H. E.; et al. (2008). JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update. Nucleic Acids Research, 36, D102-D106. doi: 10.1093/nar/gkm955.
49. Benjamini, Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B (Methodological), 57, 289-300.
50. Hardin, J.; Mitani, A.; Hicks, L.; VanKoten, B. (2007). A robust measure of correlation between two genes on a microarray. BMC Bioinformatics, 8, 220. doi: 10.1186/1471-2105-8-220.
51. Hannenhalli, S.; Putt, M. E.; Gilmore, J. M.; et al. (2006). Transcriptional genomics associates FOX transcription factors with human heart failure. Circulation, 114, 1269-1276.